Why CVS Is Giving Plans A New Tool To Target High Launch Prices
Dr. Robert Dubois of the National Pharmaceutical Council (NPC) has expressed his concerns about CVS Health’s new service offering that allows
Read moreDr. Robert Dubois of the National Pharmaceutical Council (NPC) has expressed his concerns about CVS Health’s new service offering that allows
Read moreThe Trump administration moved Wednesday to give Medicare drug plans more choices in the products they can offer patients, in
Read moreLast week, the Centers for Medicare & Medicaid Services (CMS) released its 713-page proposed policy changes and updates for the
Read moreImagine a pharmaceutical market designed by Lewis Carroll’s Mad Hatter. In contrast to almost every other market, he might begin
Read moreDisasters like major storms, earthquakes, wildfires, and terrorist actions happen. Pharmacists should have plans in place that allow them to
Read moreRepresentatives from the Community Oncology Alliance (COA) joined other cancer stakeholders and policymakers on Capitol Hill today for a briefing
Read moreToo many Americans can’t readily access or afford their prescription drugs. Pharmacy benefit managers (PBMs) play a central role in
Read more(HealthDay)— Excusing the sky-high price tags of many new cancer treatments, pharmaceutical companies often blame high research and development (R&D)
Read moreMADRID (Reuters) – Cancer doctors are widening the net for immunotherapy, a hot new class of drugs that enlist the
Read moreClovis Oncology may be the middle child in the new wave of ovarian cancer treatments, but it’s hoping some new
Read more